Join Growin Stock Community!

Femasys inc.FEMY.US Overview

US StockHealthcare
(No presentation for FEMY)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

FEMY AI Insights

FEMY Overall Performance

FEMY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

FEMY Recent Performance

-5.25%

Femasys inc.

0.05%

Avg of Sector

-0.31%

S&P500

FEMY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

FEMY Key Information

FEMY Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

FEMY Profile

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Price of FEMY

FEMY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

FEMY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.67
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
16.45
PB Ratio
7.44
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
63.05%
Net Margin
-960.53%
Revenue Growth (YoY)
63.53%
Profit Growth (YoY)
56.63%
3-Year Revenue Growth
28.04%
3-Year Profit Growth
26.34%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.67
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
16.45
PB Ratio
7.44
Price-to-FCF
-
Gross Margin
63.05%
Net Margin
-960.53%
Revenue Growth (YoY)
63.53%
Profit Growth (YoY)
56.63%
3-Year Revenue Growth
28.04%
3-Year Profit Growth
26.34%
  • When is FEMY's latest earnings report released?

    The most recent financial report for Femasys inc. (FEMY) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating FEMY's short-term business performance and financial health. For the latest updates on FEMY's earnings releases, visit this page regularly.

  • What is the operating profit of FEMY?

    According to the latest financial report, Femasys inc. (FEMY) reported an Operating Profit of -3.65M with an Operating Margin of -500.93% this period, representing a growth of 28.62% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is FEMY's revenue growth?

    In the latest financial report, Femasys inc. (FEMY) announced revenue of 729.39K, with a Year-Over-Year growth rate of 31.44%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does FEMY have?

    As of the end of the reporting period, Femasys inc. (FEMY) had total debt of 8.43M, with a debt ratio of 0.52. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does FEMY have?

    At the end of the period, Femasys inc. (FEMY) held Total Cash and Cash Equivalents of 4.57M, accounting for 0.28 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does FEMY go with three margins increasing?

    In the latest report, Femasys inc. (FEMY) did not achieve the “three margins increasing” benchmark, with a gross margin of 59.7%%, operating margin of -500.93%%, and net margin of -575.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess FEMY's profit trajectory and future growth potential.

  • Is FEMY's EPS continuing to grow?

    According to the past four quarterly reports, Femasys inc. (FEMY)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.1. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of FEMY?

    Femasys inc. (FEMY)'s Free Cash Flow (FCF) for the period is -5.63M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 4.86% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of FEMY?

    The latest valuation data shows Femasys inc. (FEMY) has a Price-To-Earnings (PE) ratio of -2.65 and a Price/Earnings-To-Growth (PEG) ratio of 0.02. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.